Table 2 Univariate analysis of progression-free survival with selected factors
From: Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
Variable | Median progression-free survival (months) | Univariate analysis (P value) |
|---|---|---|
IL-6 (pg/ml) | Â | Â |
   < 2662 | 24 |  |
   ≥ 2662 | 14 | 0.021 |
Stade | Â | Â |
   I | 36 |  |
   IV | 14 | 0.009 |
Serum CA125 (U/ml) | Â | Â |
   < 319 | 29 |  |
   > 319 | 14 | 0.040 |
Residual tumor | Â | Â |
   ≤ 2 cm | 20 |  |
   > 2 cm | 11 | 0.076 |